Metastatic means the cancer has spread from the prostate to other parts of the body, like the bones, liver, or lungs. This makes the disease harder to treat since it's no longer just in one place.

Decipher Prostate Metastatic Genomic Classifier is now available for patients with metastatic prostate cancer.

Metastatic castration-resistant prostate cancer (mCRPC) is diagnosed by blood tests, imaging scans, and biopsies. Find out ...

Mohammad Mahmoud, MD, MS, reviews important updates in metastatic prostate cancer presented at AUA 2025, including promising ...

Two phase 3 trials of Merck & Co's Keytruda in metastatic castration-resistant prostate cancer (CRPC) and advanced liver cancer have ended in failure, proving once again that cancer immunotherapy ...

Brain metastases from prostate cancer (PC) seem to be more frequent than in the past, possibly because advances in the treatment of patients with castration-resistant PC have prolonged their survival.

Patients with liver metastasis have a poor prognosis and liver metastasis have been associated with the emergence of neuroendocrine prostate cancer post androgen receptor (AR) pathway inhibitors ...

Dr. Rohan Garje shares the updated recommendations for the ASCO guideline on systemic therapy for patients with metastatic castration-resistant prostate cancer. He discusses the systemic therapy ...

The Lankenau Institute of Medical Research is the first site in a clinical trial to test the safety and effectiveness of a new combination therapy for advanced, metastatic prostate cancer.

The treatment of metastatic castration-resistant prostate cancer (mCRPC ... as well as the bladder, rectum, liver, lungs, and possibly the brain. With mCRPC, androgen deprivation therapy (ADT ...